Skip to main content
OpenTrials
Completed

NCT Number: NCT00055848

Genetic Study of Familial Factors in Patients With Colon Cancer

RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer.

PURPOSE: Clinical trial to study the cancer-related genes in patients who have colon cancer or adenomatous polyps.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Wayne Memorial Hospital, Incorporated

Goldsboro, North Carolina, 27534, United States

About this study

OBJECTIVES:

  • Identify human colon neoplasia susceptibility genes in patients with colon cancer or adenomatous polyps.
  • Correlate the inheritance of novel susceptibility alleles for adenomatous polyposis of the colon with colon neoplasia in these patients.
  • Correlate colon neoplasia susceptibility with the presence of COX-2, sPLA2, and DNMT genes in these patients.
  • Identify a novel gene that governs increased susceptibility to colon adenoma and cancer in the genome of these patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

DISEASE CHARACTERISTICS:

  • Diagnosis of colon cancer or polyps at age 70 or under
  • Has a living full sibling with diagnosis of colon cancer or polyps at age 70 or under
  • No history of familial adenomatous polyposis syndrome
  • No hereditary nonpolyposis colon cancer, according to Amsterdam criteria
  • No known I1370K adenomatous polyposis of the colon susceptibility variant
  • Enrolled on 1 of the following clinical trials:
  • CLB-9581
  • CLB-89803
  • CLB-80001 NOTE: Patients do not need to be receiving protocol therapy. Patients who are outside the treatment protocol's follow-up range are eligible. Patients who discontinued therapy for any reason, including toxic effects, are eligible.

PATIENT CHARACTERISTICS:

Age

  • 70 and under at diagnosis

Other

  • No significant psychiatric illness that would preclude giving informed consent
  • No inflammatory bowel disease (in patient or sibling)

Treatment and study plan

cytogenetic analysis

Genetic

gene mapping

Genetic

microarray analysis

Genetic

Sponsors and collaborators

Lead sponsor

Alliance for Clinical Trials in Oncology

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Familial Factors in the Development of Colon Cancer

Important dates

Study start
2001
Primary completion
2010
Study completion
2010
First posted
Mar 7, 2003
Registry last updated
Jul 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.